agilon health Future Growth
Future criteria checks 1/6
agilon health is forecast to grow earnings and revenue by 62.9% and 18.9% per annum respectively. EPS is expected to grow by 58.8% per annum. Return on equity is forecast to be -10% in 3 years.
Key information
62.9%
Earnings growth rate
58.8%
EPS growth rate
| Healthcare earnings growth | 17.2% |
| Revenue growth rate | 18.9% |
| Future return on equity | -10.0% |
| Analyst coverage | Good |
| Last updated | 18 May 2024 |
Recent future growth updates
Recent updates
agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04
agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28agilon gains after boosting Medicare membership outlook
Jan 09Is There An Opportunity With agilon health, inc.'s (NYSE:AGL) 39% Undervaluation?
Dec 19agilon health: Back To Long-Term Range, Despite Underlying Market Growth
Dec 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 9,152 | -30 | 5 | N/A | 5 |
| 12/31/2025 | 7,626 | -60 | -9 | 30 | 15 |
| 12/31/2024 | 6,166 | -142 | 117 | 37 | 12 |
| 3/31/2024 | 4,866 | -202 | -185 | -143 | N/A |
| 12/31/2023 | 4,316 | -195 | -187 | -156 | N/A |
| 9/30/2023 | 3,789 | -80 | -169 | -145 | N/A |
| 6/30/2023 | 3,268 | -79 | -151 | -129 | N/A |
| 3/31/2023 | 2,789 | -83 | -200 | -168 | N/A |
| 12/31/2022 | 2,388 | -92 | -163 | -131 | N/A |
| 9/30/2022 | 2,481 | -108 | -158 | -130 | N/A |
| 6/30/2022 | 2,245 | -114 | -181 | -152 | N/A |
| 3/31/2022 | 2,074 | -391 | -145 | -131 | N/A |
| 12/31/2021 | 1,521 | -384 | -162 | -148 | N/A |
| 9/30/2021 | 1,692 | -387 | -123 | -113 | N/A |
| 6/30/2021 | 1,546 | -363 | -104 | -98 | N/A |
| 3/31/2021 | 1,340 | -69 | -74 | -68 | N/A |
| 12/31/2020 | 1,218 | -63 | -56 | -53 | N/A |
| 9/30/2020 | 1,095 | -59 | -71 | -68 | N/A |
| 12/31/2019 | 794 | -114 | -108 | -104 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AGL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AGL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AGL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AGL's revenue (18.9% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: AGL's revenue (18.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AGL is forecast to be unprofitable in 3 years.